No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
2024's 'Biggest Loses' That Could See Reversal in 2025
Piper Sandler Maintains Cytek Biosciences(CTKB.US) With Buy Rating, Cuts Target Price to $8.25
In the Wake of Cytek Biosciences, Inc.'s (NASDAQ:CTKB) Latest US$84m Market Cap Drop, Institutional Owners May Be Forced to Take Severe Actions
Cytek Biosciences to Participate in the Piper Sandler 36th Annual Healthcare Conference
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Morgan Stanley Maintains Cytek Biosciences(CTKB.US) With Hold Rating, Maintains Target Price $9